scutellarin has been researched along with Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, J; Wei, L | 1 |
| Chen, X; Huang, R; Lei, H; Long, S; Pei, Z; Shi, X; Su, H; Zhang, X | 1 |
1 trial(s) available for scutellarin and Hypertension
| Article | Year |
|---|---|
Clinical observation on Breviscapine in treating hypertension patients complicated with micro-albuminuria of renal impairment.
Topics: Adult; Aged; Albuminuria; Amlodipine; Antihypertensive Agents; beta 2-Microglobulin; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Flavonoids; Flushing; Humans; Hypertension; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Proteinuria | 2005 |
1 other study(ies) available for scutellarin and Hypertension
| Article | Year |
|---|---|
Scutellarin attenuates hypertension-induced expression of brain Toll-like receptor 4/nuclear factor kappa B.
Topics: Animals; Apigenin; bcl-2-Associated X Protein; Brain; Caspase 3; Disease Models, Animal; Gene Expression Regulation; Glucuronates; Hypertension; Interleukin-18; Interleukin-1beta; Male; Microglia; Myeloid Cell Leukemia Sequence 1 Protein; NF-kappa B; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2013 |